Hartford Investment Management Co. Sells 134 Shares of Humana Inc. (NYSE:HUM)

Hartford Investment Management Co. lowered its stake in Humana Inc. (NYSE:HUM) by 1.7% in the 3rd quarter, HoldingsChannel.com reports. The firm owned 7,580 shares of the insurance provider’s stock after selling 134 shares during the period. Hartford Investment Management Co.’s holdings in Humana were worth $2,401,000 at the end of the most recent quarter.

Other institutional investors have also recently made changes to their positions in the company. Brookstone Capital Management bought a new stake in shares of Humana in the first quarter worth about $448,000. 180 Wealth Advisors LLC grew its position in shares of Humana by 8.1% in the 1st quarter. 180 Wealth Advisors LLC now owns 1,023 shares of the insurance provider’s stock worth $355,000 after buying an additional 77 shares during the last quarter. Independence Bank of Kentucky increased its stake in shares of Humana by 93.7% during the first quarter. Independence Bank of Kentucky now owns 1,259 shares of the insurance provider’s stock valued at $437,000 after buying an additional 609 shares during the period. Opinicus Capital Inc. raised its holdings in shares of Humana by 59.1% during the first quarter. Opinicus Capital Inc. now owns 1,974 shares of the insurance provider’s stock valued at $684,000 after acquiring an additional 733 shares in the last quarter. Finally, MCF Advisors LLC lifted its stake in Humana by 36.4% in the first quarter. MCF Advisors LLC now owns 3,863 shares of the insurance provider’s stock worth $1,342,000 after acquiring an additional 1,031 shares during the period. Hedge funds and other institutional investors own 92.38% of the company’s stock.

Humana Stock Down 0.1 %

Humana stock opened at $258.41 on Friday. Humana Inc. has a 12 month low of $213.31 and a 12 month high of $527.18. The stock has a fifty day simple moving average of $310.28 and a two-hundred day simple moving average of $337.43. The company has a current ratio of 1.66, a quick ratio of 1.66 and a debt-to-equity ratio of 0.70. The firm has a market cap of $31.14 billion, a price-to-earnings ratio of 16.09, a PEG ratio of 1.91 and a beta of 0.50.

Humana (NYSE:HUM) last released its quarterly earnings data on Wednesday, July 31st. The insurance provider reported $6.96 EPS for the quarter, topping the consensus estimate of $5.89 by $1.07. The company had revenue of $29.54 billion during the quarter, compared to the consensus estimate of $28.52 billion. Humana had a return on equity of 16.12% and a net margin of 1.53%. Humana’s revenue for the quarter was up 10.4% on a year-over-year basis. During the same period last year, the company earned $8.94 EPS. Equities analysts predict that Humana Inc. will post 16.06 EPS for the current fiscal year.

Humana Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, January 31st. Investors of record on Tuesday, December 31st will be given a dividend of $0.885 per share. This represents a $3.54 dividend on an annualized basis and a yield of 1.37%. Humana’s dividend payout ratio (DPR) is 22.04%.

Wall Street Analysts Forecast Growth

Several brokerages have commented on HUM. Stephens restated an “equal weight” rating and issued a $250.00 price objective on shares of Humana in a report on Wednesday, October 9th. Truist Financial lowered their price objective on shares of Humana from $400.00 to $260.00 and set a “hold” rating for the company in a report on Friday, October 11th. Bank of America downgraded Humana from a “neutral” rating to an “underperform” rating and reduced their target price for the stock from $376.00 to $247.00 in a report on Wednesday, October 2nd. Leerink Partners lowered Humana from an “outperform” rating to a “market perform” rating and dropped their price target for the company from $400.00 to $250.00 in a research report on Wednesday, October 2nd. Finally, Piper Sandler downgraded Humana from an “overweight” rating to a “neutral” rating and decreased their price objective for the stock from $392.00 to $274.00 in a report on Thursday, October 3rd. One investment analyst has rated the stock with a sell rating, nineteen have assigned a hold rating and six have assigned a buy rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Hold” and a consensus target price of $315.33.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.